News and Trends 24 Mar 2023
Evotec receives $6.6M for tuberculosis drug discovery
On World Tuberculosis Day, Evotec SE has announced that it has received a $ 6.6 million grant from The Bill…
Germany
- Latest Posts
News and Trends 24 Mar 2023
Microbiome therapeutics biotech mbiomics raises €13M
mbiomics GmbH, a German microbiome biotech company developing the first generation of effective microbiome-based therapeutics has closed €13 million ($…
News and Trends 23 Mar 2023
Intracellular “smoke detector” discovery has skin disease therapy implications
A study by the University of Bonn in Germany could lead to therapies against skin and intestinal diseases in the…
News and Trends 14 Mar 2023
How the microbiome can predict cancer immunotherapy success
A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable treatment outcomes. An international team…
ADVERTISEMENT
News and Trends 2 Mar 2023
Partnership formed to develop miRNA to treat pancreatic cancer
RNA delivery and therapeutics company SiSaf Ltd is to collaborate with the University of Leipzig in Germany to develop targeted…
News and Trends 2 Feb 2023
Crown Bioscience acquiring Indivumed’s service business and biobank
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has entered into an agreement to…
News and Trends 6 Jan 2023
Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals
This week, we have two guests. We have conversations with Newron CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler.…
News and Trends 5 Jan 2023
Researchers discover new type of CRISPR gene scissors
Scientists at the Helmholtz Institute Würzburg in Germany, and Benson Hill, Inc. (Missouri) and Utah State University in the U.S.,…
News and Trends 19 Dec 2022
Watch: Atriva Therapeutics at BIO-Europe
Atriva Therapeutics’ mission is to develop an antiviral therapy platform against severe respiratory and systemic diseases with a high unmet…
News and Trends 19 Dec 2022
Watch: Adrenomed tackling huge issue of sepsis
Adrenomed AG is a German privately financed, clinical-stage biopharmaceutical company. Its mission is to rescue vascular integrity in order to…
ADVERTISEMENT
News and Trends 12 Dec 2022
OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data
OSE Immunotherapeutics SA has presented the latest preclinical data on the use of its anti-IL-7 receptor (IL-7R) antagonist OSE-127 for…
News and Trends 6 Dec 2022
INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer
OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project funded by Horizon Europe. In…
News and Trends 2 Dec 2022
Partnership to deliver oncology workflow for 7 European hospitals
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been awarded a contract for the…
News and Trends 2 Dec 2022
Creating designer immune cells at scale
To prevent testing on animals and create more precise ways of testing therapeutics, the pharmaceutical industry is turning to human…
News and Trends 25 Nov 2022
New function of CRISPR gene scissors discovered
For several years, the CRISPR/Cas9 gene scissors have been causing a sensation in science and medicine. Researchers from the Institute…
Interview 23 Nov 2022
What recent mixed clinical results can teach about Alzheimer’s disease
2022 has provided mixed fortunes for companies aiming to slow Alzheimer’s disease. Ulrich Dauer, CEO of the German biotech Vivoryon,…
ADVERTISEMENT
News and Trends 23 Nov 2022
Concern as study says new covid sub-variant is resistant to all therapeutic antibodies
All approved antibody therapies for Covid-19 are ineffective against the Omicron sub-lineage BQ.1.1. That’s the worrying news following a recent…
News and Trends 22 Nov 2022
CatalYm raises €50M to boost solid tumors trial
CatalYm has announced the close of a €50 million ($49 million) series C financing round. The oversubscribed round was co-led…
News and Trends 18 Nov 2022
Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics
This week, we have three interviews on the theme of antimicrobial resistance (AMR), to mark World Antimicrobial Awareness Week. We…
News and Trends 17 Nov 2022
FundaMental Pharma launches with €10M to advance first-in-class neuroprotectant
FundaMental Pharma GmbH, a preclinical neuroscience company spun out of Heidelberg University in Germany, has launched with €10 million ($10.4…